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ABSTRACT 
 
Polycystic kidney disease is one of the common inherited diseases affecting the renal system, though it can be an 
acquired condition too. It can present as wide variety of symptoms and can also be incidental finding on abdominal 
imaging done for some other purpose. Polycystic kidney disease can be missed for a long duration if a strong 
suspicion is not there in the mind of physician based on the in detail knowledge of this condition. We here are 
presenting a short case report of a middle aged female who was having polycystic kidney disease but diagnosed 
considerably late.  
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Introduction 
 
Polycystic kidney disease (PKD) is most common 
inherited disease affecting kidneys. Prevalence of PKD 
is estimated between 1 in 400 to 1 in 1,000 in general 
population[1]. Nearly half of the individuals go 
undetected during their lifetime [2], still 5-7% cases of 
end stage renal disease can be attributed to PKD[3]. 
Most of these patients with end stage renal disease 
require dialysis or renal transplantation in due course 
of the disease. PKD is of two types - autosomal 
dominant (ADPKD) and autosomal recessive 
(ARPKD). ADPKD is more common of the two with 
incidence of 1 in 8004 live births and is further divided 
into two types depending upon the gene involved. 
ADPKD-1 is caused by mutation in PKD-1 gene on 
chromosome 16 and account for 85-90% cases of 
ADPKD, mutations in PKD-2 on chromosome 4 
accounts for rest 10-15%.4 ADPKD-1 is associated  
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with more severe disease manifesting clinically in first 
half of sixth decade of life as compared to ADPKD-2 
which manifests after 70years of age[5]. ARPKD is 
less common, incidence of 1 in 20,000 and causing 
death in fetal and neonatal period[4].PKD manifests 
with wide range of symptoms which may be due to 
cysts themselves and complications. As the cysts (and 
kidney) enlarge in size, they cause local pressure on the 
tissue and stretching of the renal capsule or traction of 
renal pedicle[6]. This leads to pain which may be felt 
in flank, in low back region centrally or on one side or 
as deep seated vague abdominal discomfort. Torsion of 
the cyst or any hemorrhage or infection in the cyst can 
also cause pain but this pain is usually acute and severe 
pain[7] and associated with other constitutional 
symptoms. PKD can manifest as hamaturia or 
albuminuria. Nephrolithiasis is also more common in 
ADPKD than general population, patient can present 
with symptoms from renal stones [8]. PKD is one of 
the etiology of hypertension, so all the symptomology 
of hypertension can be the first manifestation of PKD. 
Hypertension occurs in 3/5 of ADPKD patients and 
these patients are more prone to develop target organ 
damage[9]. Extrarenal manifestations from extrarenal 
features of PKD like cerebral aneurysms, cysts in liver, 
pancreas and other places can be the presenting 
complaints of PKD. 
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Case Report 
 
A housewife of 45 years age presented to the outdoor 
section of Guru Nanak Dev Hospital and Govt. 
Medical College, Amritsar with chief complaints of 
low backache and headaches. To start with, she had 
low backache about one and half year back. The 
backache was like a continuous discomfort which was 
not severe enough to make her stop daily routine 
housework and it was nearly static since then. Only 
occasionally, she had to take brufen or some other 
painkiller to relieve pain on the suggestion of local 
practitioners. Once she was diagnosed to be having 
PIVD (prolapsed intervertebral prolapsed disc) despite 
a normal MRI scan and no history of any trauma. She 
was even prescribed lumbosacral brace. Then about 
two months back, she started having on and off 
headache. She took advice from some clinic which 
advised her to take painkillers when required but the 
headaches continued to come and go, she decided to 
get consultation in from some other practitioner where 
she was diagnosed to have migraine and put on 
flunarizine. But she was not relieved with the 
treatment, so she reported to us. She had no brother or 
sister and her parents had died. On examination, she 
was found to be hypertensive with blood pressure of 
180/100 mmHg which was not known to her 
previously. Rest of the physical examination and 
laboratory tests including blood sugar, HbA1c , ECG, 
echocardiography showed no abnormality. High blood 
pressure with low backache, it was thought to rule out 
polycystic kidney disease and she was sent for 
ultrasonography of abdomen. Ultrasonograph revealed 
enlarged kidneys with multiple cysts in both the 
kidneys, with size of cysts ranging between 8mm to 
nearly 5cm in diameter (Pic. 1 and Pic. 2). Luckily, she 
had not any cyst in other abdominal organs. She was 
put on treatment for hypertension with ramipril and 
instructed to remain in followup. She was advised 
regarding avoidance of NSAIDs to relieve headaches 
and backache. On follow up, her blood pressure was 
under control and she had no headaches (which in all 
probability were due to high blood pressure).  
 
Discussion 
 
 As seen in our patient, PKD as the diagnosis 
can be easily missed if all the symptoms of the patient 
and examination finding are not put in a proper 
algorithm with strong suspicion of PKD. Early 
detection of PKD is very important as it will enable the 
treating physician to keep under control the medical 
complications arising from PKD like hypertension, 
cardiovascular risk and nephrolithiasis. Strict control of 
hypertension from the start is very important as PKD 
patients will progress to end stage renal disease more 
rapidly. There are two criteria to diagnose the ‘at risk’ 
individuals with renal cysts based on the 
ultrasonography findings. Ravine et al proposed 
presence of at least two renal cysts (unilaterally or 
bilaterally) for the age group 15-29 years, at least two 
cysts in each kidney for 30-59 years and at least four 
cysts in each kidney for age ≥ 60 years.10 But this 
criterion is often inaccurate for PKD-2 patients. For 
PKD-2 patients Pei et al criterion is superior.11 
According to this criteria, for those with family history 
of ADPKD of unknown genotype diagnosis requires 
the following: in age group of 15-39 years, the 
presence of three or more unilateral or bilateral kidney 
cysts; in 40-59 years age group, two or more cysts in 
each kidney; and in individuals ≥ 60 years of age, at 
least four cysts in each kidney.[11]  So in light of the 
above criteria, our patient was clearly in ‘at risk’ group 
who needs an active intervention. Blood pressure 
control goal in PKD patients is <140/90 mmHg with no 
sign of target organ damage and <130-135/80-85 
mmHg in those with target organ damage[12]. More 
intensive control of blood pressure in range of 120-
125/80 mmHg results in reduction of albuminuria and 
left ventricular hypertrophy[13]. For control of blood 
pressure in PKD patients, ACE inhibitors and ARBs 
are first line drugs as they act on RAAS (rennin-
angiotension-aldosterone system) which is 
overactivated in PKD-associated hypertension. Beta-
blockers can be considered after ACEIs and ARBs. 
Diuretics are second line drugs as they activate RAAS 
and can deteriorate the overall disease. Similarly 
Calcium channel blockers are also third line drugs, 
only to be used in resistant hypertension[14]. 
 
Conclusion 
 
As complications of the disease lead to progression of 
target organ damage more rapidly in PKD patients than 
general population, early detection of PKD is important 
to control the progression of complications arising 
from the disease and to some extent the disease itself. 
Rigorous control of blood pressure, detection of 
extrarenal manifastations of PKD and detection & 
control of co-morbidities like diabetes in PKD patients 
can significantly decrease the end stage renal renal 
disease and cardiovascular complications.   
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Fig 1 & 2: Ultrasonograph revealed enlarged kidneys with multiple cysts in both the kidneys, with size of 
cysts ranging between 8mm to nearly 5cm in diameter  
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